Position in PRTA
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$2,363,550
-$829,381 QoQ
Shares Held
241,425
-26.5% QoQ
Ownership
0.470%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#33
of 187 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in PRTA Over Time
Shares Held
Position Value (USD)
Derivatives in PRTA
reported options exposure · as of Mar 31, 2022CallValue
$1,462,800
CallShares
40,000
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026UBS Group AG holds $8,751,173,307 across 562 Biotechnology names. PRTA ranks #203 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RVMD |
Revolution Medicines, Inc.
|
5,450,825 | $1,020,369,609 | |
| 2 | ROIV |
Roivant Sciences Ltd.
|
17,466,641 | $618,144,423 | |
| 3 | PTGX |
Protagonist Therapeutics, Inc
|
3,399,221 | $416,676,508 | |
| 4 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
712,259 | $353,800,411 | |
| 5 | MRNA |
Moderna, Inc.
|
4,463,211 | $312,558,664 | |
| 6 | INSM |
INSMED Inc
|
2,584,446 | $275,553,630 | |
| 7 | ABVX |
Abivax S.A.
|
1,844,918 | $245,853,771 | |
| 8 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
401,708 | $215,697,109 |
All Filings in PRTA
Export CSV
27 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,363,550 | 241,425 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $3,192,931 | 328,491 | Shares | Defined | 2026-05-05 | |
| 2025-12-31 | $4,071,737 | 426,360 | Shares | Defined | 2026-01-29 | |
| 2025-09-30 | $3,912,265 | 400,847 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $368,229 | 60,664 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $3,025,425 | 244,479 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $5,142,323 | 371,287 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $1,045,724 | 62,506 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $924,010 | 44,768 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $4,921,302 | 198,680 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $4,814,940 | 132,497 | Shares | Defined | 2024-02-09 | |
| 2023-09-30 | $2,183,408 | 45,252 | Shares | Defined | 2023-11-09 | |
| 2023-06-30 | $1,527,764 | 22,375 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $2,987,835 | 61,643 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $5,486,907 | 91,069 | Shares | Defined | 2023-02-08 | |
| 2022-09-30 | $372,813 | 6,149 | Shares | Defined | 2022-11-10 | |
| 2022-06-30 | $565,344 | 20,823 | Shares | Defined | 2022-08-10 | |
| 2022-03-31 | $1,462,800 | 40,000 | Call | Defined | 2022-05-16 | |
| 2022-03-31 | $1,770,682 | 48,419 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $3,673,976 | 74,372 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $5,521,535 | 77,517 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $85,443 | 1,662 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $605,040 | 24,086 | Shares | Defined | 2021-05-12 | |
| 2020-12-31 | $103,561 | 8,623 | Shares | Defined | 2021-02-11 | |
| 2020-09-30 | $8,091 | 810 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $18,848 | 1,802 | Shares | Defined | 2020-07-31 | |
| 2020-03-31 | $193,498 | 18,084 | Shares | Defined | 2020-05-01 | |
| No filing history on record for this holder in this stock. | ||||||